Guardant Health
GH
#1137
Rank
NZ$36.64 B
Marketcap
NZ$273.05
Share price
-4.17%
Change (1 day)
138.82%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company